Ran Nussbaum, Director at LB PHARMACEUTICALS INC (LBRX), bought 1,411,681 shares at $15.00 ($15.0M) on 2025-09-12, disclosed to the SEC on 2025-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 411,681 | $0 | 0.0% |
| 2 | $15.00 | 1,000,000 | $15.0M | 100.0% |
| Total | $10.63 avg | 1,411,681 | $15.0M | 100% |
| Filing → |
| ARQL | BUY | 2019-07-01 | $4.1M | — | Filing → |
| ELOX | BUY | 2019-06-26 | $1.8M | — | Filing → |
| ARQL | BUY | 2018-10-22 | $1.5M | — | Filing → |